Showing 3751-3760 of 6035 results for "".
- The Vision Council Examines Consumers’ Attitudes About COVID-19 in a Survey for Its Membershttps://modernod.com/news/the-vision-council-examines-consumers-attitudes-about-covid-19-in-a-survey-for-its-members/2477382/The Vision Council released a new COVID-19 Optical Impact consumer survey. Conducted by The Vision Council’s research team in February, the study surveyed more than 10,000 adults across the U.S. and was designed to measure respondents’ level of concern over exposure to COVID-19, including measure
- Everads Therapy Enters Into Option Agreement to License Suprachoroidal Delivery System for Retinal Diseasehttps://modernod.com/news/everads-therapy-enters-into-option-agreement-to-license-suprachoroidal-delivery-system-for-retinal-disease/2477376/Everads Therapy announced that it has signed an option agreement with a large global pharmaceutical company, which will support the potential of its technology to overcome certain risks and side effects associated with current retinal disease treatment options, according to a company news release
- AbbVie-Allergan Deal Foes Try Again to Spur an FTC Crackdownhttps://modernod.com/news/abbvie-allergan-deal-foes-try-again-to-spur-an-ftc-crackdown/2477311/AbbVie and Allergan’s megamerger is likely in the final stages of review after the pair agreed to offload three drugs, including IL-23 hopeful brazikumab. But a cadre of union and consumer groups say that’s not enough—and they’re taking another stab at turning regulators against
- Santen: VISIONARY Study Demonstrates Effectiveness of Tafluprost/Timolol Combination Therapy in Open-Angle Glaucomahttps://modernod.com/news/santen-visionary-study-demonstrates-effectiveness-and-tolerability-of-tafluprost-timolol-combination-therapy-in-open-angle-glaucoma/2477305/Santen has announced that the results of its real world evidence study, VISIONARY, have been published in Advances in Therapy. The study, which was conducted in 12 countries from across Europe with up to 6-mo
- LumiThera to Expand Research into Diabetic Retinopathy for Valeda Light Delivery Systemhttps://modernod.com/news/lumithera-to-expand-research-into-diabetic-retinopathy-for-valeda-light-delivery-system/2477299/LumiThera announced it has initiated further studies with the University of Wisconsin-Milwaukee to establish the use of their Photobiomodulation platform in diabetic retinopathy (DR). “Recent research in our labs in both preclinical and clinical areas hav
- Santen and Verily Establish Joint Venture to Develop and Commercialize Unique Ophthalmic Deviceshttps://modernod.com/news/santen-and-verily-establish-joint-venture-to-develop-and-commercialize-unique-ophthalmic-devices/2477285/Santen Pharmaceutical and Alphabet subsidiary Verily announced the establishment of a joint venture focused on applying microelectronics and scalable digital technologies to ophthalmology. The new joint venture is driven by a mission to improve eye health for people everywhere, starting by
- Regeneron: Eylea Reduced Risk of Developing Vision-Threatening Events by 75% After 2 Years in Patients With DRhttps://modernod.com/news/regeneron-eylea-reduced-risk-of-developing-vision-threatening-events-by-75-after-two-years-in-patients-with-dr/2477283/Regeneron Pharmaceuticals announced positive 2-year results from the phase 3 PANORAMA trial evaluating Eylea (aflibercept) injection 2 mg (0.05 mL) in patients with moderately severe to severe nonproliferative diabetic retinopathy (NPDR). The data were presented for the first time at the Angiogen
- Bausch + Lomb and TerraCycle Partner to Launch Canada’s First and Only Contact Lens Recycling Programhttps://modernod.com/news/bausch-lomb-and-terracycle-partner-to-launch-canadas-first-and-only-contact-lens-recycling-program/2477265/Bausch + Lomb announced that it has partnered with international recycling company TerraCycle to launch the Bausch + Lomb Every Contact Counts recycling program in select eye care offices across Canada. Through the joint initiative, Canadians who wear conta
- The Vision Council Notes That U.S.-China Trade Agreement Will Result in Tariff Reductions on Certain Optical Productshttps://modernod.com/news/the-vision-council-notes-that-u-s-china-trade-agreement-will-result-in-tariff-reductions-on-certain-optical-products/2477239/The trade deal between the US and China that requires structural reforms to China’s economic and trade regimes will also lead to a modification of a portion of the existing Section 301 China tariffs, according to The Vision Council, as
- IrisVision and Samsung Announce Partnership to Roll Out Vision Correction Software Platformhttps://modernod.com/news/irisvision-and-samsung-announce-partnership-to-roll-out-vision-correction-software-platform/2477229/Samsung Electronics and IrisVision announced a strategic partnership to roll out IrisVision’s technology worldwide. IrisVision’s vision correction software platform utilizes the power of Samsung’s industry leading Galaxy smartphones and XR devices and mobile AI platform to enable people